Market Place
Sourcing Support
cGMP Non-Compliance Recap 2019
In 2019, concerns over quality of medicines continued to dominate news headlines. The ‘sartan&
Teva CEO steps down; FDA Warning Letters to firms in Japan, India & China
This week, Phispers highlights more bad news for Israeli drugmaker Teva, along with news on the &lsq
Novartis’ plant shut down creates urgency to find alternatives to Chinese APIs
With Novartis shutting two plants in Germany and one in India by 2016-end, the global reliance on Ch
